# Sunitinib malate

NDC: 63304-092
Generic name: Sunitinib malate
Labeler / Manufacturer: Sun Pharmaceutical Industries Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20191225

FDA application: ANDA213914

## Active ingredients

- SUNITINIB MALATE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63304-092"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63304-092
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=06e0ad28-6637-4f54-879c-2c194aece5fd